These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38548215)

  • 1. The emerging role of lactate in tumor microenvironment and its clinical relevance.
    Chen S; Xu Y; Zhuo W; Zhang L
    Cancer Lett; 2024 May; 590():216837. PubMed ID: 38548215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression.
    Chen L; Huang L; Gu Y; Cang W; Sun P; Xiang Y
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rising star involved in tumour immunity: Lactylation.
    Zhang X; Liang C; Wu C; Wan S; Xu L; Wang S; Wang J; Huang X; Xu L
    J Cell Mol Med; 2024 Oct; 28(20):e70146. PubMed ID: 39417674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactate and lactylation: Behind the development of tumors.
    Dai E; Wang W; Li Y; Ye D; Li Y
    Cancer Lett; 2024 Jun; 591():216896. PubMed ID: 38641309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Ink Lactate Modulates Epigenomic Landscape: A Concerted Role of Pro-tumor Microenvironment and Macroenvironment During Carcinogenesis.
    Sharma NK; Pal JK
    Curr Mol Med; 2021; 21(3):177-181. PubMed ID: 32436828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactylation, a Novel Metabolic Reprogramming Code: Current Status and Prospects.
    Chen AN; Luo Y; Yang YH; Fu JT; Geng XM; Shi JP; Yang J
    Front Immunol; 2021; 12():688910. PubMed ID: 34177945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of histone lactylation on the tumor microenvironment and metabolic pathways and its potential in cancer therapy.
    Zhou J; Ma X; Liu X; Liu Y; Fu J; Qi Y; Liu H
    Genes Genomics; 2024 Sep; 46(9):991-1011. PubMed ID: 39127851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone lactylation regulates cancer progression by reshaping the tumor microenvironment.
    Qu J; Li P; Sun Z
    Front Immunol; 2023; 14():1284344. PubMed ID: 37965331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone lactylation: from tumor lactate metabolism to epigenetic regulation.
    Yu X; Yang J; Xu J; Pan H; Wang W; Yu X; Shi S
    Int J Biol Sci; 2024; 20(5):1833-1854. PubMed ID: 38481814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactate in the tumour microenvironment: From immune modulation to therapy.
    Wang ZH; Peng WB; Zhang P; Yang XP; Zhou Q
    EBioMedicine; 2021 Nov; 73():103627. PubMed ID: 34656878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The crosstalking of lactate-Histone lactylation and tumor.
    Rong Y; Dong F; Zhang G; Tang M; Zhao X; Zhang Y; Tao P; Cai H
    Proteomics Clin Appl; 2023 Sep; 17(5):e2200102. PubMed ID: 36853081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactate-induced protein lactylation: A bridge between epigenetics and metabolic reprogramming in cancer.
    Wang T; Ye Z; Li Z; Jing DS; Fan GX; Liu MQ; Zhuo QF; Ji SR; Yu XJ; Xu XW; Qin Y
    Cell Prolif; 2023 Oct; 56(10):e13478. PubMed ID: 37060186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel lactylation-related signature to predict prognosis for pancreatic adenocarcinoma.
    Peng T; Sun F; Yang JC; Cai MH; Huai MX; Pan JX; Zhang FY; Xu LM
    World J Gastroenterol; 2024 May; 30(19):2575-2602. PubMed ID: 38817665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role and Mechanism of Lactylation in Cancer].
    Zhang Q; Cao L; Xu K
    Zhongguo Fei Ai Za Zhi; 2024 Jun; 27(6):471-479. PubMed ID: 39026499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactate metabolism in human health and disease.
    Li X; Yang Y; Zhang B; Lin X; Fu X; An Y; Zou Y; Wang JX; Wang Z; Yu T
    Signal Transduct Target Ther; 2022 Sep; 7(1):305. PubMed ID: 36050306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactate: The Mediator of Metabolism and Immunosuppression.
    Zhang Y; Zhai Z; Duan J; Wang X; Zhong J; Wu L; Li A; Cao M; Wu Y; Shi H; Zhong J; Guo Z
    Front Endocrinol (Lausanne); 2022; 13():901495. PubMed ID: 35757394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering lactate-modulating nanomedicines for cancer therapy.
    Chen J; Zhu Y; Wu C; Shi J
    Chem Soc Rev; 2023 Feb; 52(3):973-1000. PubMed ID: 36597879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oncogenic and clinical implications of lactate induced immunosuppression in the tumour microenvironment.
    Hayes C; Donohoe CL; Davern M; Donlon NE
    Cancer Lett; 2021 Mar; 500():75-86. PubMed ID: 33347908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of lactate-lactylation in malignancy: its potential in immunotherapy.
    Zha J; Zhang J; Lu J; Zhang G; Hua M; Guo W; Yang J; Fan G
    Front Immunol; 2024; 15():1384948. PubMed ID: 38779665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the interaction of glycolytic reprogramming with lactylation.
    Li Y; Cao Q; Hu Y; He B; Cao T; Tang Y; Zhou XP; Lan XP; Liu SQ
    Biomed Pharmacother; 2024 Aug; 177():116982. PubMed ID: 38906019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.